OKAY
833230
CHANGFU CO.,LTD
871396
Gansu Longshenrongfa Pharmaceutical Industry
300534
4
Tibet Duo Rui Pharmaceutical
301075
5
Chengda Pharmaceuticals
301201
CN Stock MarketDetailed Quotes
000065 NORINCO International Cooperation
- 10.65
- +0.25+2.40%
Not Open Apr 1 15:00 CST
11.39BMarket Cap10.86P/E (TTM)
10.75High10.48Low215.23KlotVolume10.48Open10.40Pre Close229.33MTurnover2.21%Turnover Ratio10.86P/E (Static)1.07BShares13.5052wk High1.17P/B10.37BFloat Cap8.0752wk Low11.44Limit Up973.38MShs Float21.00Historical High9.36Limit Down2.60%Amplitude1.28Historical Low0.09Dividend TTM10.66Avg Price86.56KlotAsk0.86%Div YieldTTM100Lot Size120.09KlotBid
NORINCO International Cooperation Key Stats
All
YOY
| (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | -5.05%19.21B | 1.20%14.2B | 17.99%10.41B | 7.01%4.47B | 37.17%20.23B | 38.82%14.03B | 69.72%8.82B | 128.28%4.18B | 9.66%14.75B | 41.96%10.11B |
| Refunds of taxes and levies | -11.74%501.63M | -20.85%362.96M | -17.16%276.31M | -15.98%149.65M | 10.13%568.36M | 25.26%458.6M | 53.13%333.54M | 115.92%178.11M | 3.94%516.07M | -6.39%366.13M |
| Cash received relating to other operating activities | -37.03%638.61M | 20.69%464.5M | -42.13%332M | -7.83%181.23M | 14.82%1.01B | -38.48%384.87M | 71.10%573.75M | -1.95%196.62M | -47.32%883.33M | 71.90%625.6M |
| Cash inflows from operating activities | -6.71%20.35B | 1.03%15.03B | 13.24%11.01B | 5.47%4.8B | 35.08%21.81B | 34.02%14.88B | 69.17%9.73B | 115.44%4.55B | 3.36%16.15B | 40.94%11.1B |
| Goods services cash paid | -7.32%17.4B | 0.43%13.57B | 11.81%10.2B | 18.14%4.06B | 40.22%18.77B | 36.40%13.51B | 66.37%9.13B | 33.99%3.43B | 17.85%13.39B | 31.19%9.91B |
| Staff behalf paid | 15.35%915.22M | 19.19%679.4M | 16.50%468.89M | 9.54%160.71M | 20.72%793.42M | 17.07%570.01M | 33.90%402.47M | 27.56%146.7M | 25.18%657.21M | 24.99%486.9M |
| All taxes paid | 16.66%665.06M | 8.74%505.59M | 9.00%362.94M | 54.25%111.81M | 67.44%570.09M | 127.33%464.96M | 174.30%332.99M | 35.85%72.49M | 55.84%340.47M | 52.15%204.53M |
| Cash paid relating to other operating activities | -26.53%712.12M | 26.43%730.96M | 15.49%361.76M | -32.30%134.08M | -4.98%969.25M | -6.14%578.17M | -30.90%313.25M | -24.90%198.05M | -49.45%1.02B | -21.15%616.01M |
| Cash outflows from operating activities | -6.70%19.69B | 2.39%15.48B | 12.02%11.4B | 15.90%4.46B | 36.99%21.11B | 34.89%15.12B | 59.96%10.17B | 28.59%3.85B | 9.09%15.41B | 26.62%11.21B |
| Net cash flows from operating activities | -6.94%653.35M | -83.46%-456.76M | 14.48%-383.95M | -51.75%338.72M | -4.87%702.06M | -119.98%-248.97M | 26.59%-448.97M | 179.65%702.06M | -50.71%738.03M | 88.45%-113.18M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | 161.18%4.83M | ---- | ---- | ---- | -82.81%1.85M | ---- | ---- | ---- | -93.62%10.75M | -90.80%11.73M |
| Cash received from returns on investments | -84.82%1.3M | ---- | --0 | ---- | -22.83%8.54M | ---- | ---- | 17,258.82%913.65K | 309.24%11.06M | -45.53%377.39K |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | -34.68%982.46K | -6.45%920.99K | -13.30%505.25K | 1.55%325.64K | 85.14%1.5M | 31.01%984.5K | 8.90%582.78K | 591.66%320.68K | -38.83%812.34K | -40.54%751.49K |
| Cash received relating to other investing activities | 329.45%429.45M | 183.18%39.7M | ---- | 3,144.35%8.95M | -61.54%100M | --14.02M | --6.11M | --275.76K | --260M | ---- |
| Cash inflows from investing activities | 290.17%436.55M | 170.74%40.62M | -92.46%505.25K | 514.03%9.27M | -60.41%111.89M | 16.64%15M | 171.81%6.7M | 2,825.00%1.51M | 63.71%282.63M | -90.08%12.86M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -1.56%184.25M | 88.42%151.52M | 300.57%119.11M | -43.74%14.19M | -41.29%187.16M | 9.69%80.42M | -48.75%29.73M | -45.00%25.22M | -54.39%318.78M | -76.83%73.31M |
| Cash paid to acquire investments | -29.03%298.97M | -29.12%298.8M | -23.94%156.55M | --141.93M | 20.70%421.25M | 20.78%421.53M | -41.03%205.82M | ---- | -69.05%349.01M | -52.99%349.01M |
| Cash paid relating to other investing activities | -60.00%120M | --113.86M | 3,001.21%110M | ---- | 47.96%300M | ---- | 16,790.47%3.55M | ---- | -58.62%202.76M | --4.14M |
| Cash outflows from investing activities | -33.60%603.22M | 12.40%564.17M | 61.30%385.66M | 518.95%156.12M | 4.35%908.41M | 17.70%501.95M | -41.26%239.1M | -93.60%25.22M | -62.42%870.54M | -59.73%426.46M |
| Net cash flows from investing activities | 79.08%-166.67M | -7.52%-523.55M | -65.73%-385.15M | -519.27%-146.84M | -35.48%-796.52M | -17.74%-486.95M | 42.56%-232.4M | 93.98%-23.71M | 72.58%-587.91M | 55.49%-413.59M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | ---- | ---- | ---- | ---- | ---- | -99.99%101.98K | -100.00%42.97K | ---- | --1.17B | --1.17B |
| Cash from borrowing | -15.01%2.25B | -13.61%2.24B | 13.60%2.02B | -92.68%50.97M | -6.99%2.65B | 5.02%2.6B | -20.60%1.78B | -7.43%696.71M | 24.05%2.85B | 35.54%2.47B |
| Cash received relating to other financing activities | ---- | ---- | ---- | ---- | ---- | --481.66K | ---- | --23.79K | ---- | ---- |
| Cash inflows from financing activities | -15.01%2.25B | -13.63%2.24B | 13.60%2.02B | -92.68%50.97M | -34.01%2.65B | -28.65%2.6B | -47.82%1.78B | -7.43%696.73M | 74.84%4.02B | 99.56%3.64B |
| Borrowing repayment | -37.30%1.81B | -10.02%1.77B | 40.09%1.46B | -81.92%177.59M | 16.90%2.88B | 1.97%1.97B | -35.10%1.04B | 163.06%982.15M | -17.76%2.46B | 50.99%1.93B |
| Dividend interest payment | 17.44%333.98M | 8.07%268.61M | 73.71%204.27M | 2.59%50.49M | 20.50%284.38M | 71.56%248.55M | 181.92%117.59M | 146.20%49.21M | -4.02%236M | -30.62%144.88M |
| -Including:Cash payments for dividends or profit to minority shareholders | 167.82%40.45M | --1.04M | --1.04M | --1.04M | 640.50%15.1M | ---- | ---- | ---- | 749.35%2.04M | ---- |
| Cash payments relating to other financing activities | 2.58%24.46M | -60.06%4.66M | 140.47%2.74M | 52.65%1.38M | -2.22%23.84M | 594.52%11.67M | 55.18%1.14M | 85.76%906.5K | 243.98%24.38M | 103.60%1.68M |
| Cash outflows from financing activities | -32.12%2.16B | -8.26%2.04B | 43.61%1.66B | -77.77%229.46M | 17.04%3.19B | 7.30%2.23B | -29.56%1.16B | 162.11%1.03B | -16.15%2.72B | 39.56%2.08B |
| Net cash flows from financing activities | 116.73%89.7M | -46.00%199.53M | -42.59%355.18M | 46.80%-178.49M | -141.42%-536.28M | -76.37%369.51M | -64.87%618.7M | -193.51%-335.53M | 236.30%1.29B | 364.71%1.56B |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | 112.03%1.6M | -176.29%-26.8M | -178.90%-26.88M | -101.30%-28.52M | 42.60%-13.33M | -58.22%35.13M | 83.70%34.07M | -5,756.79%-14.17M | 72.47%-23.22M | 298.57%84.08M |
| Net increase in cash and cash equivalents | 189.74%577.98M | -143.77%-807.58M | -1,441.68%-440.8M | -104.60%-15.13M | -145.30%-644.08M | -129.54%-331.28M | -103.74%-28.59M | 135.87%328.64M | 184.59%1.42B | 169.42%1.12B |
| Add:Begin period cash and cash equivalents | -14.24%3.88B | -16.72%3.88B | -16.39%3.88B | -14.24%3.88B | 45.86%4.52B | 50.19%4.66B | 49.59%4.64B | 45.86%4.52B | -35.15%3.1B | -35.15%3.1B |
| End period cash equivalent | 14.90%4.46B | -29.01%3.07B | -25.43%3.44B | -20.36%3.86B | -14.24%3.88B | 2.45%4.33B | 19.29%4.61B | 122.08%4.85B | 45.86%4.52B | 33.35%4.22B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- |
| Auditor | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.